SBIR/STTR Research Award
STTR Phase I: Oral Cancer Detection Using Redox Magnetohydrodynamic Microfluidics-based Bioassay Chips
Award amount
$150,000Program and phase
STTR · Phase IAward year
2007Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- SFC FLUIDICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- GTPCCLD8LK26
- Solicitation number
- NSF 06-598
- Topic code
- BT
Research abstract
This Small Business Technology Transfer Research (STTR) Phase I project aims to develop a molecular signature-based redox magnetohydrodynamic (MHD) microfluidic system for the detection of oral cancer. The microfluidic chips are expected to interface with a handheld readout instrument that has a low operator skill requirement and is suited for point-of-care operation.If successful, the methodology can be used for early detection of oral squamous cell carcinoma, as well as other forms of cancer and as such may benefit a large number of individuals suffering from cancer.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Advanced Development of Gemini-DHAP
- Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor
- Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals
- Development of a Low Profile Dual Hormone Patch Pump with Novel Occlusion Sensor
- Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals
Research funding history
17 SBIR/STTR records share this UEI (2004–2023). Reported award amounts total $9,636,875. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: National Science Foundation, Department of Health and Human Services, Department of Defense, National Aeronautics and Space Administration